Tag: Robert Snyder

Innovative Treatment Utilizing an Autologous Blood Clot for Diabetic Foot Ulcers

Marie Williams, David Davidson, Naz Wahab, Jessie Hawkins, Chinenye D. Wachuku, Robert Snyder


Diabetic foot ulcer is among the most common complications of uncontrolled diabetes and is associated with an increased risk of mortality.1 The annual incidence of DFUs worldwide ranges between 9.1 million and 26.1 million.1 It is estimated that approximately 15% to 25% of patients with diabetes will develop a DFU in their lifetime, resulting in increased incidence of hospitalizations and amputations.1,2 In the United States, the total annual medical cost for the management of DFUs ranges between $9 billion and $13 billion … read more

It’s Time to #BreakTheSilence on Diabetic Foot Ulcers

RedDress is launching a nationwide public awareness campaign, “Break the Silence,” educating Americans about the prevalence and prevention methods of diabetic foot ulcers.

Diabetic foot ulcers are sometimes omitted from the national discussion about diabetes and its complications. “Break the Silence” aims to reduce the stigmas associated with diabetic foot ulcers, while promoting and educating Americans about the prevalence and risk factors associated with this complication of diabetes. “Break the Silence” will run through November and coincide with National Diabetes Awareness Month.

Approximately 25 percent of diabetics will suffer a diabetic foot ulcer in their lifetime, according to the Centers for Disease Control and Prevention (CDC). 1,2

“These ulcers are as serious as some cancers. We need to have a national conversation. Right now, we’re looking at diabetes in very broad strokes. I think we have to have a greater dialogue and more information about diabetic foot ulcers, in general,” expressed Dr. Robert Snyder, Dean of Barry University School of Podiatric Medicine in Miami, one of our partner physicians participating in the “Break the Silence ” campaign … read more